Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Oral Contraceptives in Polycystic Ovary Syndrome: Risk-Benefit Assessment
Link ID 4890
Title Oral Contraceptives in Polycystic Ovary Syndrome: Risk-Benefit Assessment
Url http://www.medscape.com/viewarticle/572203?src=rss
Description Safety of long-term oral contraceptive pill (OCP) use in polycystic ovary syndrome, particularly adverse cardiometabolic effects, is controversial. What are the long-term benefits and risks of OCPs?
Seminars in Reproductive Medicine
Category Articles > Cardiology
Keywords
Date Apr 16, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Cardiology
1. ONTARGET MRI Study: No Benefit of Combination Therapy on Left Ventricular Mass
  A new ONTARGET imaging study has shown no difference between ramipril, telmisartan, or the combination in the reduction of left ventricular mass. The MRI study, say investigators, closely parallels the main findings from ONTARGET, showing no clear advantage to combination therapy. Heartwire
Category:   Articles > Cardiology


2. Meta-Analysis Shows That Statins Reduce the Incidence and Recurrence of AF
  French investigators showed that the use of statins was significantly associated with a decreased risk of incidence or recurrence of atrial fibrillation in patients in sinus rhythm with a history of previous AF, those undergoing cardiac surgery, or those prescribed the drugs after an acute coronary syndrome. The findings, say investigators, point to the benefit of statins beyond their ability to lower LDL cholesterol. Heartwire
Category:   Articles > Cardiology


3. More Donations of Medical and Nursing Books Arrive in Iraq
  A physician working in Iraq writes to thank donors for the many books and journals that have been sent. More are needed. Would you consider a holiday donation?
Topics in Advanced Practice Nursing eJournal
Category:   Articles > Cardiology


4. MEND-CABG II: No Benefit of MC-1 in Reducing Death/MI Post-CABG
  The lead investigator says the drug, based on a metabolite of vitamin B6, likely has no future as a cardioprotective agent in bypass surgery but may yet prove to have other beneficial metabolic properties, provided its developer has deep enough pockets to continue to study it. Heartwire
Category:   Articles > Cardiology


5. Risk Factors Identified for Sudden Death in Myotonic Dystrophy Type 1
  A 10-year study of adult patients with myotonic dystrophy type 1 confirms their high risk for arrhythmias and sudden death, and identifies factors that appear to predict high risk: patients with severe abnormalities on ECG and atrial tachyarrhythmias had a 3.5- and 5-fold increased risk respectively. Medscape Medical News
Category:   Articles > Cardiology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS